CG Oncology, Inc. (NASDAQ:CGON) Receives Average Recommendation of “Buy” from Analysts
CG Oncology, Inc. (NASDAQ:CGON – Get Free Report) has been assigned a consensus rating of “Buy” from the eight analysts that are covering the stock, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month target price among […]
More Stories
FSC Wealth Advisors LLC Increases Stock Holdings in JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI)
FSC Wealth Advisors LLC lifted its stake in JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI – Free Report) by 5.0% in...
FSC Wealth Advisors LLC Makes New $71,000 Investment in UBS Group AG (NYSE:UBS)
FSC Wealth Advisors LLC purchased a new position in UBS Group AG (NYSE:UBS – Free Report) in the 3rd quarter,...
Entergy Co. (NYSE:ETR) Shares Acquired by Stanley Laman Group Ltd.
Stanley Laman Group Ltd. grew its stake in Entergy Co. (NYSE:ETR – Free Report) by 2.8% during the third quarter,...
Wintrust Financial (NASDAQ:WTFC) Announces Earnings Results
Wintrust Financial (NASDAQ:WTFC – Get Free Report) issued its quarterly earnings results on Monday. The bank reported $2.47 earnings per...
SAP (NYSE:SAP) Releases Quarterly Earnings Results, Misses Expectations By $0.08 EPS
SAP (NYSE:SAP – Get Free Report) released its quarterly earnings data on Monday. The software maker reported $1.23 earnings per...
Intra-Cellular Therapies (ITCI) to Release Quarterly Earnings on Wednesday
Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) is set to release its earnings data before the market opens on Wednesday,...